Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: CircLIFRSA/miR-1305/PTEN axis attenuates malignant cellular processes in non-small cell lung cancer by regulating AKT phosphorylation

Fig. 3

CircLIFRSA serves as an early diagnostic biomarker for lung cancer. (A) The standard curve was used in absolute quantitation. (B) The expression levels of circLIFRSA in whole blood of healthy people (n = 49), benign lung disease (n = 30), and NSCLC (n = 60) were detected by RT-qPCR. (C) ROC curve of circLIFRSA distinguishing benign lung disease from cancer patients. (D) ROC curve of circLIFRSA distinguishing early stage I from other stages (II-IV) in NSCLC patients.*** P < 0.001

Back to article page

Molecular Cancer

ISSN: 1476-4598